December 6, 2017

Discredited Weight Loss Drug Shows Promise for Seizure Disorder

Discredited Weight Loss Drug Shows Promise for Seizure Disorder Forward to a friend | View Online
8975842d-d31a-4ad4-95a9-bcce47223048.jpg
Discredited Weight Loss Drug Shows Promise for Seizure Disorder
American Epilepsy Society —

Fenfluramine, part of the weight loss combination drug Fen-Phen that was withdrawn from the market in 1997 at the request of the FDA amid concerns linking the drug to severe heart valve damage, may have anti-seizure effects in people with Dravet syndrome, a type of epilepsy. 

Read More »
Having Hot Flashes? You May Be at Higher Risk for Diabetes
The North American Menopause Society —

Severe symptoms of menopause – hot flashes and night sweats, for example – may be associated with an increased risk for developing type 2 diabetes.


Read More »
Popular Blood Pressure Drug Raises Skin Cancer Risk
Journal of the American Academy of Dermatology —

A common blood pressure drug may raise your skin cancer risk, say Danish researchers in a study published in the Journal of the American Academy of Dermatology.


Read More »
What Is the Fortnight Diet? Does It Work?
Berkeley Wellness —

To increase the likelihood of successful long-term weight loss, this twist on a calorie-restricted diet may be worth trying: Alternate two weeks on the diet with two weeks off.


Read More »
Quiz: Are You at Risk for Stomach Cancer?
HealthCentral —

Stomach cancer, also called gastric cancer, usually develops slowly over many years and early changes don't always cause symptoms. Take our quiz to help determine your risk.


Read More »
imp?s=187247&sz=300x250&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5
imp?s=187248&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=187249&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5
imp?s=95371&sz=116x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=96074&sz=69x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5
More from Health Central
The Remedy Health Network
Berkeley Wellness science-backed, expert-vetted health and wellness advice

The Body current and complete coverage for the HIV/AIDS community
Newsletter Options
This email was sent to clrmyers6@gmail.com

We're happy to help you unsubscribe or manage your email preferences.

If this email was forwarded to you by another email recipient and you would like to subscribe, click here.

Ensure you receive this newsletter by adding us to your safe sender's list.

You can also forward this newsletter to a friend.
t.png p.png
imp?s=124359000&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359001&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359002&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359003&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359004&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359005&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359006&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359007&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359008&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359009&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359010&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359011&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359012&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359013&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359014&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359015&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359016&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359017&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359018&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5 imp?s=124359019&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=34e96db5a5

No comments:

Post a Comment